Streetbeat News

Credit

ARES

KKR

KKR is set to acquire a minority stake in an Eni unit, with funding support from Ares and banks. KKR will utilize $1.6 billion in debt for this acquisition.

Portfolio Pulse from Benzinga Newsdesk

October 25, 2024 | 3:02 pm

TPX

Tempur Sealy has successfully closed a $1.6 billion Term Loan B facility, which will mature in seven years. This financial move is significant for the company's capital structure.

Portfolio Pulse from Nabaparna Bhattacharya

October 25, 2024 | 10:56 am

LILM

Lilium's principal German subsidiaries are set to apply for self-administration proceedings due to insolvency issues. This move follows a failed loan approval process with KfW in the German parliament.

Portfolio Pulse from Benzinga Newsdesk

October 24, 2024 | 9:03 pm

PII

Polaris (NYSE:PII) has received mixed ratings from analysts over the past three months, with a recent decline in average price targets. Analysts have lowered their ratings and price targets, reflecting concerns over Polaris's recent revenue decline and high debt levels, despite strong net margins and returns on equity and assets.

Portfolio Pulse from Benzinga Insights

October 24, 2024 | 7:01 pm

WFC

Wells Fargo's CEO announced that the bank might incur a loss of $2 billion to $3 billion on its commercial real estate (CRE) portfolio. However, the bank has already reserved for these potential losses, which de-risks its balance sheet.

Portfolio Pulse from Benzinga Newsdesk

October 24, 2024 | 6:29 pm

WFC

Wells Fargo CEO Charlie Scharf reports that the U.S. consumer is performing well, with credit levels in single digits and consistent. However, uncertainty around U.S. elections is causing clients to pause on loan demand.

Portfolio Pulse from Benzinga Newsdesk

October 24, 2024 | 6:21 pm

JPM

JPMorgan Chase CEO Jamie Dimon stated that the bank is not over-earning on credit currently, and highlighted the ongoing uncertainty in the regulatory and legal environment.

Portfolio Pulse from Benzinga Newsdesk

October 24, 2024 | 5:06 pm

BPMC

Analysts have provided a range of ratings for Blueprint Medicines (NASDAQ:BPMC) over the past three months, with a majority being bullish. The average 12-month price target has increased by 4.13% to $120.17. Blueprint Medicines has shown significant revenue growth but faces challenges in debt management and return on equity.

Portfolio Pulse from Benzinga Insights

October 24, 2024 | 3:00 pm

SLM

SLM Corp, the largest student lender in the US, has received mixed analyst ratings over the past three months. Analysts have set a 12-month price target range of $24 to $27, with an average of $26. Recent ratings include downgrades and upgrades from firms like Barclays, JP Morgan, and B of A Securities. Despite revenue challenges, SLM shows strong net margin, ROE, and ROA, but faces high debt-to-equity ratio risks.

Portfolio Pulse from Benzinga Insights

October 24, 2024 | 1:01 pm

SPY

The Federal Reserve's Hammack reports that inflation has eased while the job market remains strong and growth is good. However, housing-related inflation may persist. More disinflation is expected.

Portfolio Pulse from Benzinga Newsdesk

October 24, 2024 | 12:57 pm